1-8 of 8
Thomas Pabst, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prospective Long-Term Follow-up after First-Line Subcutaneous Cladribine Treatment in Patients with Hairy Cell Leukemia. a Study of the SAKK (Swiss Group for Clinical Cancer Research)

Rudolf A. Benz, MD, Kornelius Arn, MD, Martin Andres, Thomas Pabst, MD PhD, Urban Novak, Felicitas Hitz, MD, Reinhard Zenhäusern, Yves Chalandon, MD PhD, Ulrich Mey, MD, Sabine Blum, Daniel Rauch, Willy Nettekoven, Nathan Cantoni, MD, Mario Bargetzi, MD, Alix O'Meara, MD, Andreas Lohri, MD, Simona Berardi, PhD BSc, Qiyu Li, Georg Stussi, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2875.
https://doi.org/10.1182/blood-2018-99-114301
Published: 2018
Journal Articles

Argx-110 Targeting CD70, in Combination with Azacitidine, Shows Favorable Safety Profile and Promising Anti-Leukemia Activity in Newly Diagnosed AML Patients in an Ongoing Phase 1/2 Clinical Trial

Adrian F Ochsenbein, MD, Carsten Riether, PhD, Ulrike Bacher, Rouven Müller, MD, Sabine Höpner, PhD, Yara Banz, Magdalena Hinterbrandner, Msc, Mario Bargetzi, MD, Markus G. Manz, MD, Luc Van Rompaey, PhD, Mahan Moshir, MSc, Tim Delahaye, MSc, Domenica Gandini, MD PhD, Ellen Erzeel, Anna Hultberg, PhD, Samson Fung, MD, Hans De Haard, PhD, Nicolas Leupin, MD, Thomas Pabst, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2680.
https://doi.org/10.1182/blood-2018-99-118302
Published: 2018
Journal Articles

Rituximab Maintenance Treatment for a Maximum of 5 Years in Follicular Lymphoma: Final Results of the Randomized Phase III Trial SAKK 35/03

Christian Taverna, MD, Giovanni Martinelli, MD, Felicitas Hitz, MD, Walter Mingrone, MD, Thomas Pabst, MD PhD, Lidija Cevreska, MD PhD, Auro del Giglio, MD, Anna Vanazzi, MD, Daniele Laszlo, MD, Johann Raats, Daniel Rauch, Daniel Vorobiof, Andreas Lohri, MD, Emanuele Zucca, Celine Rueegsegger, Stephanie - Rondeau, Corinne Rusterholz, Michele Ghielmini
Journal: Blood
Blood (2018) 132 (Supplement 1): 1601.
https://doi.org/10.1182/blood-2018-99-116864
Published: 2018
Journal Articles

Prospective Molecular MRD Detection By NGS: A Powerful Independent Predictor for Relapse and Survival in Adults with Newly Diagnosed AML

Mojca Jongen-Lavrencic, MD PhD, Tim Grob, MD, Francois G. Kavelaars, Adil S.A. Al Hinai, Annelieke Zeilemaker, Claudia A.J. Erpelinck-Verschueren, Yvette Norden, Rosa Meijer, PhD, Bart J. Biemond, MD PhD, Carlos Graux, Marinus van Marwijk Kooij, MD PhD, Markus G. Manz, MD, Thomas Pabst, MD PhD, Violaine Havelange, MD PhD, Jakob R. Passweg, MD PhD, Gert J. Ossenkoppele, MD PhD, Gerrit Jan Schuurhuis, PhD, Mathijs A. Sanders, PhD, Bob Löwenberg, MD PhD, Peter J.M. Valk, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): LBA-5.
https://doi.org/10.1182/blood.V130.Suppl_1.LBA-5.LBA-5
Published: 2017
Journal Articles

Prevention of Venous Thrombotic Events in Adult Patients with Acute Lymphoblastic Leukemia Treated in a Pediatric-Inspired Protocol - a Graall Study

Corentin Orvain, Marie Balsat, MD, Véronique Lhéritier, Emmanuelle Tavernier, Jean-Pierre Marolleau, MD PhD, Thomas Pabst, MD PhD, Patrice Chevallier, MD PhD, Noémie De Gunzburg, MD, Victoria Cacheux, Francoise Huguet, MD, Sylvain Chantepie, MD, Denis Caillot, Yves Chalandon, MD, Jamilé Frayfer, MD, Caroline Bonmati, MD, Nicolas Boissel, MD PhD, Hervé Dombret, MD PhD, Norbert Ifrah, Mathilde Hunault-Berger, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2776.
https://doi.org/10.1182/blood.V128.22.2776.2776
Published: 2016
Journal Articles

The HIV Protease Inhibitor Nelfinavir in Combination with Bortezomib and Dexamethasone (NVd) Has Excellent Activity in Patients with Advanced, Proteasome Inhibitor-Refractory Multiple Myeloma: A Multicenter Phase II Trial (SAKK 39/13)

Christoph Driessen, MD PhD, Rouven Müller, MD, Urban Novak, MD, Nathan Cantoni, MD, Daniel Betticher, Nicolas Mach, Michael Gregor, Panagiotis Samaras, MD, Catherine Berset, Stephanie Rondeau, Hanne Hawle, MD, Felicitas Hitz, MD, Thomas Pabst, MD PhD, Thilo Zander, MD
Journal: Blood
Blood (2016) 128 (22): 487.
https://doi.org/10.1182/blood.V128.22.487.487
Published: 2016
Journal Articles

The Upper Age Limit for a Pediatric-Inspired Therapy in Younger Adults with Ph-Negative Acute Lymphoblastic Leukemia (ALL)? Analysis of the Graall-2005 Study

Françoise Huguet, MD, Thibaut Leguay, Xavier Thomas, MD PhD, Nicolas Boissel, MD PhD, Martine Escoffre-Barbe, MD, Patrice Chevallier, MD PhD, Mathilde Hunault, MD PhD, Norbert Vey, MD, Caroline Bonmati, MD, Stéphane Leprêtre, MD, Jean-Pierre Marolleau, MD PhD, Thomas Pabst, MD PhD, Philippe Rousselot, MD PhD, Agnès Buzyn, MD PhD, Jean-Yves Cahn, MD, Véronique Lhéritier, Marie C Béné, PharmD, PhD, Vahid Asnafi, MD PhD, Eric Delabesse, PharmD, PhD, Elizabeth Macintyre, MD PhD, Yves Chalandon, MD, Norbert Ifrah, Hervé Dombret, MD
Journal: Blood
Blood (2016) 128 (22): 762.
https://doi.org/10.1182/blood.V128.22.762.762
Published: 2016
Journal Articles

High Prognostic Impact of Flowcytometric Minimal Residual Disease Detection In Acute Myeloid Leukemia: Prospective Data From the HOVON/SAKK 42a Study

Monique Terwijn, Angèle Kelder, Wim L.J. van Putten, Alexander N. Snel, Vincent H.J. van der elden, PhD, Rik A. Brooimans, PhD, Nancy Boeckx, MD, PhD, Frank W.M.B. Preijers, PhD, Bob Löwenberg, MD, PhD, Angelika M. Dräger, PhD, Peter C. Huijgens, MD, PhD, Peter J.M Valk, PhD, Johan Maertens, MD, Thomas Pabst, MD, PhD, Gert J. Ossenkoppele, MD, PhD, Gerrit J. Schuurhuis, PhD
Journal: Blood
Blood (2010) 116 (21): 760.
https://doi.org/10.1182/blood.V116.21.760.760
Published: 2010